VRS System Verification at HDA 2020 Traceability Seminar

Posted on October 30th, by Gary Lerner in Events, News, Pharmaceuticals, Regulations.

FDA Extends Saleable Returns Verification until 2023

Posted on October 23rd, by Gary Lerner in News, Pharmaceuticals, Regulations.

FDA is concerned that large volume of saleable returns coupled with the challenges of establishing reliable and robust technology may disrupt the distribution of prescription drugs in the United States. FDA does not intend to take action against wholesale distributors who do not, prior to November 27, 2023, verify the product identifier prior to further distributing returned product. This is a 3-year delay from the current date of enforcement. FDA also does not intend to take action against dispensers who do not verify the product identifiers of suspect product as required by DSCSA before November 27, 2023.

GS1 Connect 2019: Attaining Interoperability and Overcoming the Challenges

Posted on June 12th, by Gary Lerner in Integrity Matters.